41
Prostaglandins & NSAIDs Cheryl Tajon October 13, 2008 Review Session: Exam 1 Walter Holleran

Prostaglandins Nsaids Review08

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Prostaglandins Nsaids Review08

Prostaglandins & NSAIDs

Cheryl TajonOctober 13, 2008

Review Session: Exam 1Walter Holleran

Page 2: Prostaglandins Nsaids Review08

Lehninger Principles of Biochemistry, 3rd Edition, Nelson, D. and Cox, M., p.378

Formation of Eicosanoids

1° pathway

Page 3: Prostaglandins Nsaids Review08

Lehninger Principles of Biochemistry, 3rd Edition, Nelson, D. and Cox, M., p.378

Formation of Eicosanoids

1° pathway

C20:4 or 20:4∆5, 8, 11, 14

Page 4: Prostaglandins Nsaids Review08

Essential fatty acids (EFA’s)

912

Page 5: Prostaglandins Nsaids Review08

Cyclooxygenase (COX) mechanism

COX-2 PDB = 6COX

Page 6: Prostaglandins Nsaids Review08

Cyclooxygenase (COX) mechanism

COX-2 PDB = 6COX

Page 7: Prostaglandins Nsaids Review08
Page 8: Prostaglandins Nsaids Review08

I

1 unsaturated bond

Saturated

Page 9: Prostaglandins Nsaids Review08

I

1 unsaturated bond

Saturated

Bridged bicyclic system 2 fused rings

Bridged bicyclic system

Page 10: Prostaglandins Nsaids Review08

ω-3 FA’s (like PGE3) are generated from eicosapentaenoic acid.

Page 11: Prostaglandins Nsaids Review08

•Induces uterine contractions•Prepares cervix for labor & delivery•Induces abortion (1st & 2nd trimester)

•PGI2 analogue•Treats hypertension•Disadvantage: requires a central line•Short half-life (3-5 min)

•Treats impotence•Given as an injection or urethral suppository

•Synthetic PGE1 analogue•Prevents NSAID-induced ulcers•C16 methyl increases stability and half-life

Page 12: Prostaglandins Nsaids Review08
Page 13: Prostaglandins Nsaids Review08

Arachidonic acid

COX

Present in blood platelets

Thromboxanes induce constriction of blood vessels and platelet aggregation (blood clotting).

Low doses of aspirin, taken regularly, reduce the probability of heart attacks and strokes.Lehningher Principles of Biochemistry, 3rd Ed., p.785

Page 14: Prostaglandins Nsaids Review08
Page 15: Prostaglandins Nsaids Review08

COX: “cyclic” pathway

Lipoxygenase: “linear” pathway; found in leukocytes; incorporates molecular oxygen into arachidonate (5-hydroperoxyeicosatetraenoate)

Chemoattractant for neutrophils

Page 16: Prostaglandins Nsaids Review08

Arachidonic acid

lipoxygenase

Page 17: Prostaglandins Nsaids Review08

What conditions are NSAIDs used?

• 1o: treat inflammation, mild to moderate pain, & fever

• Specific uses: headaches, arthritis, sports injuries, menstrual cramps

• Included in cold/allergy preparations

Page 18: Prostaglandins Nsaids Review08

Molecular target for NSAIDs

•COX is a homodimer.•Active sites for COX1 & 2 are different.

•COX2 has an extended binding pocket that can be utilized for selectivity.

•All COX inhibitors, regardless of selectivity, bind in the arachidonic acid binding site.

TiPS – Nov 1999 (vol. 20)

Page 19: Prostaglandins Nsaids Review08

• Inhibits by acetylating a serine residue in the active site.

Prototype NSAIDs

CO2H

O

O

Aspirin

HO Ser

Enzyme

Acetylation

CO2H

OH

Salicylic acid

+O

O

Ser

Enzyme

•However, NSAIDs can also inhibit synthesis of beneficial prostaglandins in GI tract and kidney.

Page 20: Prostaglandins Nsaids Review08

acid

Critical single carbon bridge

•Ibuprofen•(S) is the active enantiomer.

•Less potent, more liver toxicity w/o -CH3 group

Page 21: Prostaglandins Nsaids Review08

Aryl Propionic Acidsnaphthalene

isobutyl

Page 22: Prostaglandins Nsaids Review08

Indole Acids

Page 23: Prostaglandins Nsaids Review08
Page 24: Prostaglandins Nsaids Review08

COX has two isozymes.

• Both carry out the same reactions, but

COX-1

Active under normal healthy conditions

COX-2

Normally dormant; when activated produces excess

inflammatory prostaglandins

H2NO2S

NO

Valdecoxib

MeO2S

O

O

Refecoxib

H2NO2S

NN

CF3

Celecoxib

Selective COX-2 inhibitors:

Page 25: Prostaglandins Nsaids Review08

Flurbiprofen

DuP 697

Page 26: Prostaglandins Nsaids Review08

General structure for COX2 Selective NSAIDs

• Consist of a central ring with 1,2-biaryl substitution

X X

S

F

SO2CH3

Br

DuP 697

NN

F

SO2CH3

CF3

SC 58125

F

SO2CH3

F

SO2CH3

SC 57666

Page 27: Prostaglandins Nsaids Review08
Page 28: Prostaglandins Nsaids Review08
Page 29: Prostaglandins Nsaids Review08

Acetaminophen Toxicity

Page 30: Prostaglandins Nsaids Review08

Leukotriene Synthesis

•Targeting FLAP will inhibit 5-lipoxygenase

Page 31: Prostaglandins Nsaids Review08

•Inhibits synthesis of leukotrienes•Approved 10yrs ago for asthma

Page 32: Prostaglandins Nsaids Review08

Arachidonic acid

lipoxygenase

Page 33: Prostaglandins Nsaids Review08

•Not much SAR

•Asthma•Can take orally

•Recently approved•Less effective than steroids

Page 34: Prostaglandins Nsaids Review08

•Present at physiological pH.•Develop antagonists of this species against H1

receptor.

Page 35: Prostaglandins Nsaids Review08

Basic N

Linker; variability in X & Y

Usually methyl, but not always

1st generation antihistamines crossed blood-brain barrier.

Page 36: Prostaglandins Nsaids Review08
Page 37: Prostaglandins Nsaids Review08

Basic N

X

•Weakly or non-sedating•Don’t cross blood-brain barrier•Both compounds are metabolized by Cyt P450.

Page 38: Prostaglandins Nsaids Review08

•Prodrug•No longer used

•Active drug•Not converted in the reverse fashion

Page 39: Prostaglandins Nsaids Review08

All are competitive and bind with increased affinity for TNFα.Humira

Remicade

Enbrel

Page 40: Prostaglandins Nsaids Review08

Important in gout; used in combination with methotrexate.

Purpose: to reduce binding of leukocytes to the endothelium

Page 41: Prostaglandins Nsaids Review08